Will A Second Trump Term be a Financing Boon for Healthcare?

The impact of private equity investments in healthcare under the new administration is multifaceted. While deregulation and business-friendly policies could stimulate investment and drive innovation, there are significant concerns about the potential negative effects on healthcare quality and access. The post Will A Second Trump Term be a Financing Boon for Healthcare? appeared first on…

Read More

California’s Much-Touted IVF Law May Be Delayed Until 2026, Leaving Many in the Lurch

California lawmakers are poised to delay the state’s much-ballyhooed new law mandating in vitro fertilization insurance coverage for millions, set to take effect July 1. Gov. Gavin Newsom has asked lawmakers to push the implementation date to January 2026, leaving patients, insurers, and employers in limbo. The law, SB 729, requires state-regulated health plans offered…

Read More

Improving Patient Trust with Digital Communication

Patients need tailored touchpoints throughout their health journey to stay engaged with their care plan. To do this effectively, healthcare organizations must leverage technology and digital communication strategies to drive and retain patient engagement and experience end-to-end.  The post Improving Patient Trust with Digital Communication appeared first on MedCity News.

Read More

Setting the Record Straight on the FDA’s Authority Over Drug Ads

Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. Clarifying the FDA’s Role and Authority Over Direct-to-Consumer Drug Ads While several inaccuracies in the recent opinion piece about direct-to-consumer prescription drug advertisements by KFF Health News’ Elisabeth Rosenthal have been…

Read More